#Influenza and Other Respiratory Viruses Research #References (AMEDEO, July 19 '26)

 

BMC Pediatr

1. CHOO MY, Lum LCS, Jalal MIA, Ooi KS, et al
   Nutritional disparities between urban poor and non-poor Malaysian children under five in the context of the COVID-19 pandemic: a cross-sectional study.
   BMC Pediatr. 2026 Jun 5. doi: 10.1186/s12887-026-07079.
   PubMed         Abstract available
   
   
2. KENDRIC KJ, Durrani TS
   Trends in pediatric household cleaning product exposures before and during the COVID-19 pandemic: a national poison data system analysis (2016-2023).
   BMC Pediatr. 2026;26:658.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

3. AMEMIYA Y, Nishiura H
   Using forensic autopsy data to estimate the age-specific infection fatality risk of COVID-19.
   Epidemiol Infect. 2026;154:e96.
   PubMed         Abstract available
   
   
4. MCGEOCH L, Stoker K, Rome M, Carey C, et al
   What is the burden of respiratory syncytial virus outbreaks in care homes? An enhanced surveillance study in England, winter 2024/25.
   Epidemiol Infect. 2026;154:e99.
   PubMed         Abstract available
   
   

   
   J Epidemiol Community Health

5. WING K, Morton C, Mahalingasivam V, Costello RE, et al
   Occurrence and persistence of symptoms, diagnoses and prescriptions after community-diagnosed COVID-19: a matched cohort study using the OpenSAFELY platform.
   J Epidemiol Community Health. 2026;80:624-634.
   PubMed         Abstract available
   
   

   
   J Infect Dis

6. FLANNERY B, Chung JR, Holiday C, Jefferson S, et al
   Influenza Antibody Levels Associated with Laboratory-Confirmed Influenza in a Test-Negative Study Design, US Flu VE Network, November 2018-May 2019.
   J Infect Dis. 2026 Jul 17:jiag371. doi: 10.1093.
   PubMed         Abstract available
   
   
7. KAWAI N, Bando T, Kawashima T, Matsuura S, et al
   Influenza Attack Rates and Vaccine Effectiveness by Prior-Season Infection and Vaccination: A 17-Season Analysis.
   J Infect Dis. 2026 Jul 11:jiag352. doi: 10.1093.
   PubMed         Abstract available
   
   
8. ROGERS S, Sumner KM, Yang Y, Johnson E, et al
   Protective effects of influenza B neuraminidase antibodies against symptomatic influenza virus infection.
   J Infect Dis. 2026 Jul 10:jiag351. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Virol

9. CIMINSKI K, Reuther P, Rijkers R, de Vries RP, et al
   The receptor landscape of influenza A viruses.
   J Virol. 2026 Jul 16:e0144325. doi: 10.1128/jvi.01443.
   PubMed         Abstract available
   
   
10. SHIRAZI R, Kim SY, Cruz A, Stumpff JP, et al
    RELMalpha establishes a permissive environment for influenza virus infection through direct effects on lung epithelial cells.
    J Virol. 2026 Jul 16:e0222525. doi: 10.1128/jvi.02225.
    PubMed         Abstract available
    
    

    
    Lancet

11. BLAKNEY AK, Top KA, Cowling BJ, Larson HJ, et al
    Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.
    Lancet. 2026 Jun 30:S0140-6736(26)00512-X. doi: 10.1016/S0140-6736(26)00512.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

12. DA SILVA K, Naffakh N, Rameix-Welti MA, Lemoine F, et al
    Accounting for Defective Viral Genomes in viral consensus genome reconstruction, application to influenza virus.
    PLoS Comput Biol. 2026;22:e1014115.
    PubMed         Abstract available
    
    

    
    PLoS One

13. OKUI T
    Difference in excess mortality during the COVID-19 pandemic depending on marital status in Japan.
    PLoS One. 2026;21:e0354263.
    PubMed         Abstract available
    
    
14. KARIM A, Al Mamun MA, Sultana S, Kabilan MK, et al
    Teaching persuasive essay writing online to first-year undergraduates: A phenomenological study of instructional design and learning experiences.
    PLoS One. 2026;21:e0353171.
    PubMed         Abstract available
    
    
15. MICHEL S, Kempf C, Pirschtat N, Herbstreit F, et al
    Herpesvirus reactivation is associated with mortality in critically ill ICU patients with COVID-19: Insights from a retrospective single-center analysis of 455 cases.
    PLoS One. 2026;21:e0354153.
    PubMed         Abstract available
    
    
16. MA C, Sun J, Liu Z, Zhang C, et al
    Skin manifestations of primary COVID-19 infection with the omicron variant.
    PLoS One. 2026;21:e0352201.
    PubMed         Abstract available
    
    
17. MADDEN D
    Covid-19 related excess mortality: An analysis by age for selected countries.
    PLoS One. 2026;21:e0353766.
    PubMed         Abstract available
    
    
18. BOMANS S, Michotte N, El M'Rabet I, Jimenez Garcia B, et al
    Agreement and reliability between the two-day 6-minute incremental step test and two-day cardiopulmonary exercise test in post COVID-19 condition for assessing post-exertional malaise: The REVEAL-study.
    PLoS One. 2026;21:e0353132.
    PubMed         Abstract available
    
    
19. CAPODICI A, Filippeschi A, Noci F, Michelucci A, et al
    Mapping global inequities in telemedicine implementation: An umbrella review of barriers and facilitators.
    PLoS One. 2026;21:e0351885.
    PubMed         Abstract available
    
    
20. WIELAND V, Wassmuth N, Contento L, Kuhn M, et al
    Assessment of simulation-based inference methods for stochastic compartmental models in epidemiological research.
    PLoS One. 2026;21:e0353306.
    PubMed         Abstract available
    
    
21. DILILLO KM, Forconi CS, Matta A, Melo J, et al
    Estimating SARS-CoV-2 exposure in asymptomatic hospitalized children with cancer in Western Kenya: A retrospective analysis of serological data.
    PLoS One. 2026;21:e0353284.
    PubMed         Abstract available
    
    
22. ROBINSON B, Bisaillon P, Sandhu R, Khalil M, et al
    Semi-analytical hierarchical Bayesian inference of nonlinear model structure in stochastic dynamics: Applied to compartmental models of infectious diseases.
    PLoS One. 2026;21:e0350747.
    PubMed         Abstract available
    
    
23. ROSYCHUK RJ, Lee BE, Qiu JY, Gao T, et al
    Exploring the predictability of distributed lag nonlinear models using SARS-CoV-2 wastewater-based surveillance in multiple communities in Alberta, Canada.
    PLoS One. 2026;21:e0349030.
    PubMed         Abstract available
    
    
24. KAYUMBA K, Duga A, Papa Fallah M, Tshidibi C, et al
    Adverse events following immunization during COVID-19 mass vaccination campaigns in the Democratic Republic of Congo: Findings from active safety surveillance.
    PLoS One. 2026;21:e0309628.
    PubMed         Abstract available
    
    

    
    Vaccine

25. TU T, Tseng CY, Islam MD, Hsu WL, et al
    Adjuvant-free pH-controlled aggregates of E. coli-expressed H1N1-RBD enhance neutralizing antibody responses and confer protection against influenza virus.
    Vaccine. 2026;88:128898.
    PubMed         Abstract available
    
    
26. GROOTENDORST A, Paludan-Muller AS, Madsen K, Stovring H, et al
    Expanding enhanced influenza vaccines programs for adults aged >/=65 in the Nordic region predicted to improve public health and health system resilience.
    Vaccine. 2026;88:128934.
    PubMed         Abstract available